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ABSTRACT
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Pirinixic acid (WY-14,643) was discovered as 
?? ??????????? ??????????????????????? ????????? ????????
???????????????????????????????????????????????????????????
in clinical use for the treatment of hypercholesterolemia 
and hypertriglyceridemia [2]. In the meantime, a 
???????????? ??????? ??? ?????????? ????? ???????????? ?????
?????????????????????????????????????????????????????????
????????????????????????????????????????????????????
microsomal prostaglandin E2 synthase-1 (mPGES1), 
????????????????????????????????????? ??????????????????
pirinixic acid derivatives drug candidates for pathological 
??????? ?????????? ?????????????? ?????????? ??????????
syndrome, hypertension, cardiovascular disease, 
????????????????????????? ?????????????????????????????
?????????




39 pirinixic acid derivatives for their effects on the 
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??????????????????????????????????????????????????????????
??????????? ????? ????? ????? ?????????????? ???? ???????? ???























??? ?????????? ?????????? ?????????? ????? ???????
????? ??????? ??????? ??? ????? ????? ??????? ??? ?????????????????????????????????????????????????????????? ?????????????????????????????????????????????????????
????????????? ?????????????????????????????????????? ????????? ?????? ???? ?????? ??????? ??? ????? ???????????? ?????????? ??????? ?????? ?????? ?????? ???????




?????????? ????????????? ????????????????????? ???
????????? ?????? ????? ??? ????? ?????? ?????? ??????? ???? ??????????????????????????????????????????????????????????????????????????????????????????????????????????
?????????????????????????????????????????????????????
?????? ?????????????????????????????? ????????????????????
??????? ??????????????? ?????????????? ?????????????????????????????????????????????????????????????????????
??????????????????????????????????? value was determined 
???????????????????????????????????????????????????????
????????????????
Effects of selected pirinixic acid derivatives 
on the viability of drug-resistant 
neuroblastoma cells
Next we compared the effects of pirinixic acid, 
????????????????????????????????????????????????????
??????????????????????????????????????????????????????????
resistance to cisplatin (UKF-NB-3r???????????????????????
(UKF-NB-3r?????), and vincristine (UKF-NB-3r?????). 
In addition, we determined the effects of these compounds 
???????????????????????????????????????????????????????????
????????????????????????????????????????????????????????
????????? ????? ?? ?????????????? ???????? ?????? ?????????
???????????????????????????????????????????????????????
????????? ?????????????????????????????




relative to UKF-NB-3. All three drug-resistant UKF-NB-3 
???????????????????????????????????????????????????????????
???????????????????????????????? ?????????????????? ???????????????????????????????????? ???????r????? cells 
????????????????????????????????????????????????????????
??????????????????????????? ??????????????????????????? ?????????????????????????????????????????????????????
??? ???????? ??? ????????????? ???????????? ?????? ??????????
????????????????????????????????????????????????????
and similar sensitivity to the other tested compounds 
???????????????????????????
Effects of selected pirinixic acid derivatives on 
the vincristine sensitivity of vincristine-resistant 
UKF-NB-3rVCR10 cells
Next, we investigated the effects of a range of 
pirinixic acid derivatives that had displayed varying effects 
??? ????????? ?????????????? ????? ???????????? ???????
??????????????????????????????????????????????????? ????????????????????????????????????? ??????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????
???? ?????????????????????? ????????? ????????? ???????
3r??????????????????????????????????????????????????????
?????????????????????????????????????????????????????????
and UKF-NB-3r????????????????? UKF-NB-3r?????????? ?????????????? ??????????????? ??????????????????????????????????????????????????????????????? 33.39 ?????????? ?????????????????????????? ????????? 17.16 ???????????????? ??????? ???????? ??? ????????????? ????
All tested pirinixic acid derivatives sensitized UKF-NB-
3r???????????????????????????????????????????????????????
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Effects of LP117 on the sensitivity of ABCB1-




???????????????????????????? in UKF-NB-3r????? cells in ???????????????????????????????????????????????????????
??????????????????????????????????????????????????????????
????????????????? ?????????????? ????? ?????? ????
32r????? and UKF-NB-2r??????????? ????????????????
??????????????????????????????????????????????????????
??????????? ??????????????? ????? ??????????????? ????????????
???? ???????????????????????????????????????????????
?????????????????r????????????????????????????????
????????????????????? ????????????????? ???????r????? 
??? ???????????? ???????? ???? ????????????? ???? ??? ??????????
????????????????????????????????????????????????? ???
??????????? ??????????????????????????????????????????
expressing UKF-NB-3r????? or UKF-NB-3r????? cells 
??????????????????????????????????????????????????????
?????? ???????? ??????????? ????????r????? 
?????? ??? ?????????? ??????????? ????????????? ????????????
???? ???????????? ?? ???? ???? ??? ???? ?????? ??????????
???????????? ??? ???? ????????? ?????????????? ?????? ??? ???
????????????????????????????????????????????????????????
Figure 1: Effects of pirinixic and its derivatives on UKF-NB-3 neuroblastoma and PC-3 prostate cancer cell viability. 
??????????????? ????? ??????? ????? ?????????? ??? ???? ???????????? ??????????? ?????? ????? ??? ??????????? ??????? ??????????? ???????????????????????????????????????????????????????????????
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????????? ??? ???????????????????????????????????????????
???????????????????????????????r????? (Figure 4, Suppl. 
??????????????????????????????????????????????????????
???????????????????? ???????????????????????????????????
?????? ???????????? ??? ????????????? ?????? ???????????
UKF-NB-3r????? and UKF-NB-3r????? cells to 
??????????????????????????????????????????????????????????
?????????????????????????????? ?????????????????????????
sensitized UKF-NB-3r?????, UKF-NB-3r?????, and 
UKF-NB-3r????? cells to all three drugs although it 
exerted much more pronounced effects on vincristine and 
??????????????????????????????????????????????????????????
????????????????????????????????? ????????????







???? ????? ?????????? ????????? ????????????? ??? ??????
??????????????????? ???????????????????????????
????????????????????????????????? ??????????????
?????? ??? ?? ???????? ??????? ??? ??????????? ???????? ???
??? ?? ??????? ???????? ??? ???? ????????????? ??????????
acid derivatives since none of the other pirinixic acid 
derivatives that sensitized UKF-NB-3r????? cells to 
??????????????????????????????? ????? ???????????????
rhodamine 123 accumulation in UKF-NB-3r????? cells in 
?????????????????????????????????????????????????
Figure 2: Effects of pirinixic acid and selected derivatives on the viability of the parental, chemosensitive UKF-NB-3 
neuroblastoma cell line, cisplatin- (UKF-NB-3rCDDP1000), doxorubicin- (UKF-NB-3rDOX20), and vincristine-resistant 





insights into the mechanisms underlying the interaction 




??????????? ?????? ??? ????????????? ????????????? ????????????
???? ???????????? ?? ???? ???? ??? ???????????? ???????? ????
?????? ?????? ???? ?????????? ???? ????????? ???????????
????????????????? ?????? ??? ???????????? ???? ???????????
????? ??? ???????????? ???????? ???? ???????? ???? ??????
??????????????????????????????????????????????????????????????
Figure 3: Effects of pirinixic acid derivatives on the sensitivity of ABCB1-expressing cell lines to the cytotoxic ABCB1 




????? ?????????? ?????? ???? ?????????? ???? ??????????
differing effects on rhodamine 123 accumulation in 
????????????????? ????????????????? ??????? ??????????
123 accumulation in UKF-NB-3r????? cells, while 
??????????????????????????????????????????????????????





a role with regard to the disparities in the relative effects 
?????????????????????????????????????????????????????????
??????????????????????????????????? ????????????????
cell lines UKF-NB-3r?????, UKF-NB-3r?????, and 
UKF-NB-3r???????????????????????????????????????????
effects on vincristine activity than on paclitaxel activity 
in all three cell lines. In contrast, verapamil exerted 
similar effects on vincristine and paclitaxel in UKF-NB-
3r????? cells, more pronounced effects on paclitaxel 
than on vincristine in UKF-NB-3r????? cells, and more 
pronounced effects on vincristine than on paclitaxel 
in UKF-NB-3r?????? ?????? ???????? ???? ????????? ??????
cell line-dependent effects of verapamil on vincristine 
???? ??????????? ???????????? ?????? ??? ???????????? ??? ????
???????????? ??? ???? ????? ????????? ????? ???? ?????????




In this study, we screened a panel of pirinixic 
????? ???????????? ???? ???????? ??? ???? ?????????? ??? ????
?????????????? ????? ????? ????????? ???? ???? ?????????
???????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????? ????????? ?????????????????????????????????????????????????????
Figure 4: Effects of LP117 on the sensitivity of the ABCB1-expressing neuroblastoma cell line UKF-NB-3rVCR10 and 
the ABCB1-expressing rhabdhomyosarcoma cell line Rh30rVCR10 to different cytotoxic ABCB1 substrates. Values are 
????????????? ?????????????????????????????????????????? ????????????????????? ??? ?????????????????????????????????????????????????????????????????????????????????????????????????
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??????????????????? ??????????????????????????????????????????????????????????????????????????????????????????





?????? ???? ?????? ?????????? ???? ??????????? ??? ??????????
??????????????????????????????????????????????????????????
?????????????????????????????????????????????????????????
Figure 5: Effects of LP117 or the ABCB1 inhibitor verapamil on the sensitivity of the ABCB1-expressing neuroblastoma 





these molecules is not critical for their anti-cancer activity 
in the investigated cell lines.
?????? ??????? ??????? ?????? ???? ????? ?????
?????????????? ??? ???????? ????????? ???????? ??? ?? ???? ???
??????????????????????????????????????????????????????????
cisplatin- (UKF-NB-3r??????????? ????????????? ?????
NB-3r?????), and vincristine-resistant (UKF-NB-
3r??????? ?????????? ??? ????????? ???????? ???? ???? ?????
?????????????? ????????????? ?????????????????????????????
????? ????????? ???????????? ????? ?? ???????? ???????????????
Figure 6: Effects of LP117 and the ABCB1 substrate verapamil on ABCB1 ATPase activity in isolated membranes 
??????????????????????????????????? ??????????????????? ???????????????? ???????rVCR10 cells. A.? ????? ??????




?????????????? ????????? ?????????? ???????? ???????? ???
???????????????????????????????????????????????????????
???????????????????????????????????????????????????????????????? UKF-NB-3 < 2. All four resistant cell lines showed ??????????????????????????????????????????????????????????
????? ??????????????? ?????? ????????????????????????????
similarly effective to UKF-NB-3 in all resistant cell lines 
???? ????????r?????, while UKF-NB-3r????? and 
???????? ?????? ????? ?????????? ??? ??????? ?????? ????????
suggest that the investigated pirinixic acid derivatives 
differ in the mechanisms underlying their effects on cancer 
???????????????
A range of pirinixic acid derivatives sensitized 
????????????????? ???????r????? cells to vincristine, 
????????????????????????????????? ????????????????????? ???????????????????????????????????????????????????????????




????? ?????? ?????? ???? ????? ??????? ????? ?????? ?????
?????????????????????????????? ???????????????????????????
?????????????????????????????????????????????????????????????
?????????????? ??????????? ??????????????? ???????r?????, 
UKF-NB-2r???????? ????????? ?????????? ???????? ???
???????????? ?????????r?????) or paclitaxel (UKF-
NB-3r???????? ???? ???? ?????????????? ?????????????????
???????????????????????? ???????????????????????????????





????? ???????????? ?????? ??????????? ??????
??????????? ?????? ??? ?????? ??????????? ??????????
?????????????????????????????????????? ?????????????????????
???????????????????? ?????????????????????????? ?????
???????????? ?????? ????? ??????? ????????? ?????????????
??????????????????????????????????????????????????????




feature of the investigated pirinixic acid derivatives since 
?????? ?????? ?????? ?????? ???? ????? ???? ???????????
????????????????????????????????????????????????????????
?????????????????????????????? ???????????????????????
Verapamil also displayed stronger effects on the sensitivity 
????????????????????????????????????????????????????????
????? ??? ????????????? ???????? in silico? ???????? ????????
????????????????????????????????????????????????????????????
??????????????????????? ????????????????????????????
??? ????????????? ????????????? ???????????? ???? ????????????
?? ????? ???? ??????????? ??? ???? ?????????????? ??????????
????????????????????????????????????????????????????????
???????????????????????????????????????????????????
????????????? ???????????????????? ?????? ??? ???? ???????




???? ????? ????? ???????? ?????? ??? ???? ??????????? ???





?????????????????? ????????? ???? ?????????? ???????????
???????????????????????????????????????????????????????????
effects of verapamil on paclitaxel and vincristine toxicity 
????????????????????? ???????????????????????????????
NB-3r?????? ????????????????????????? ????????r????? 
(paclitaxel-resistant), and UKF-NB-3r????? (vincristine-
resistant). Verapamil sensitized UKF-NB-3r????? cells to 
??????????????????????????????????????????????????????????????
more pronounced effects on paclitaxel in UKF-NB-
3r????? cells and more pronounced effects on vincristine 
in UKF-NB-3r???????????????????????????????????????????
??????????????????? ????????????????????????????????????
??? ???????????????? ??????????? ???? ???????????? ????? ???
???????????????????????????????????????????????? ????????
???????????????????
????? ????????? ??????????? ??????????
?????????????????? ??????? ?????? ??????????? ?????
????????? ??????????????????????????????????????????????
???????????????????? ???????????????????????????????????
??????? ????? ??????????? ?????????? ????????? ?????????
???????????????????????????????????????????????????????
??????? ????????? ???? ??? ???? ???????? ???? ?????? ????????? ???
??????????? ??????????? ???? ???? ????? ?????????? ????? ????
???????????????????????????????????????????? ????????
????????????????????????????????????????????????????????
??????????? ????????? ???? ??????????? ???? ?????????????
??? ?????????????? ????????????? ?????? ????? ?????????






drugs and drug penetration into the central nervous system 
[32,33].
In conclusion, we provide evidence that pirinixic 




???? ??????????? ??? ???? ????????????? ??????????





????????? ?????????????? ????? ?????? ???????? ???? ????
??? ????? ????? ??????????? ???? ?????? ???? ?????????
????????????????????????????????????????????????????
??? ???? ????? ????????? ????? ??????? ??????????? ?????????
??????????????????? ???????????? ??????????????????






32r????? (vincristine), UKF-NB-2r?????, UKF-NB-
3r???????? (cisplatin), UKF-NB-3r?????????????????????




continuous exposure to increasing drug concentrations as 
????????????????????????????????
???? ?????? ????? ??????????? ??? ????? ??? ?????
????????????????????? ????????????????????????????????
????????????????????????????????????????????????????????
??????????? ?????????????? ???? ?????????????? ??? ??????
???????????????????????
Viability assay




Determination of ABCB1 ATPase activity
???? ??????????????????????????????????????????
????????? ????????????? ???? ????????????? ????????????
????????? ???? ??? ???????????? ???? ???? ?????????????








??? ?????? ??????????????? ????? ??????? ??????????????
????????? ???????????? ???? ????????? ??? ???? ??????????




?????????? ???????? ???????????? ????? ??????????
using the most recently solved crystal structure of murine 
????????????????????????????? ????????????????????????
the highest resolution to date (3.6 ?), complexed with 
?????? ??????? ???????? ??????????? ?????????? ???? ?????????
??? ???????? ??? ?? ????????? ???? ???????? ????? ??? ???? ??????
???????? ??????? ?????????? ???????????? ???????? ???? ??????
???? ????????? ????????? ????????? ?????????? ??????
????????????????????????????????????????????????????????
??? ???? ???? ???? ???? ??????? ?????? ???? Protonate3D 
????????? ??? ???? ?????? ?????????? ??? ???????? ????????
????????????????????????????????????????????????????????
?????????????? ???? ??????? ???????????????? ??????????





?????????? ??? ???? ???????????????? ???????????????? ?????????
???????????????????????????????????????????????????????
??????? ???????? ???? ??????? ???? ???? ????????????????
???????????????????????????????????????????????????????
achieving a near-native ligand pose. All the compounds 





?????? ?????????? ??? ???? ??????????? ???? ?????????? ??? ????
?????????????????????????????????????????????????????????
????????? ??????????? ???? ???????? ?? ???????? ?? ????????
???????????????????????????????????????????????????????????
?????????????????????????????????????????????????????????
?????? ??? ??????? ??????? ????????????? ???????? ?????????
??????????????????????????????????????????????????????





???????? ???? ?????????? ??????????????? ??? ??? ??????
?????????????????????????????????????????????????? ????
????????????????????????????????????????????????????????
????? ????????? ????????? ????????? ??? ???? ????????





???? ????? ???? ?????????? ??? ???? ?????? ????
???????????? ??????? ?????????? ?????? ???? ????????????



















??? ???? ??? ????? ??? ?????? ??? ????? ??? ????? ??? ?????????
?????????? ???????????????????????????????????????????????-
tives as potent dual agonists of the peroxisome prolif-







7. ?????? ???????????????????????????? ????????????? ???????
????????????????????????????????????????????????????
??????????????????????????????????????????????????????????????
of gamma-secretase modulators with PPARgamma activity. 
?? ???????????????????????????








glandin E(2) synthase-1 as alternative to non steroidal anti-
???????????????????????????????????????????????????? ???
???????????????????????










13. ?????? ?? ???????????????????????????????????????????????-
??????????????????????? ???????????????????????????????
14. ????????????????????????????????????????????????????
??????????? ???????????????????? ?????????? ????? ???????? ???
????????????????? ???????????????????
???? ?????????? ??? ???????????? ???????????????????? ?????
?????????????? ?????????? ?? ??? ?????? ?? ????? ?????????
??????????????????????????????????????????????????????-
utazone, an oral peroxisome proliferator-activated receptor 
gamma agonist, administered to patients with advanced 
????????????????????????????????????????









???? ???????? ???? ????????? ???? ?? ?????? ??????????? ?????-










Reversal of P-glycoprotein-mediated multidrug resistance 
??????????????????????????????????????????????????????????
?????????????????????
21. ??????????? ??? ???????? ???? ??????? ??? ?????????? ???










23. ????????? ?? ??? ???? ??????? ?????? ????????? ??????
??????????????????? ????????????????? ?????????????????????
??????? ???????????????????????




????? ????????? ??????????? ??? ?? ?????? ?????? ??? ???????
?????????????????????????????
???? ????????? ??? ??????? ??? ?????????? ??? ????? ???? ??????
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????????????????????????????????????????????????????????
??????????????????
???? ??????????????? ??? ?????????????????????? ?????????????
??????????????????????????????????????
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